Gastrin Tetrapeptide

CAS : 1947-37-1

Ref. 3D-FG108885

Informations sur le produit

• Nom: Gastrin Tetrapeptide
• Synonymes: H-Trp-Met-Asp-Phe-NH2 H-WMDF-NH2, Ccris 3246, Cholecystokinin tetrapeptide, Gastrin tetrapeptide, Gastrin tetrapeptide amide, N-((Phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-L-phenylalaninamide, L-Phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-, L-Phenylalaninamide, N-((phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl-L-aspartyl-, L-Triptophyl-L-methyionyl-L-alpha-aspartyl-L-phenylalaninamide, N-[(benzyloxy)carbonyl]tryptophylmethionyl-alpha-aspartylphenylalaninamide, N-[(benzyloxy)carbonyl]-L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide, L-tryptophyl-L-methionyl-L-alpha-aspartyl-L-phenylalaninamide
• CAS: 1947-37-1

Description

Gastrin tetrapeptide is a pharmacological treatment for clinical relevance. It has been shown to be an irreversible inhibitor of the histamine H2-receptor. Activated gastrin tetrapeptide has been shown to inhibit the activity of 5-hydroxytryptamine (5-HT) receptors and κ-opioid receptors in vitro, and studies have shown that it decreases glutamate release from nerve cells, which may contribute to its antiemetic properties. Gastrin tetrapeptide has also been shown to have a physiological effect on humans, with decreased 5-HT concentrations and increased gastric pH levels being observed. This peptide is used in the treatment of infectious diseases such as malaria, which causes vomiting and diarrhea.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 596.7 g/mol
• Formule: C₂₉H₃₆N₆O₆S
• Degré de pureté: Min. 95%